tykhr
sign in
free sign up
Enliven Therapeutics Inc.
Biotechnology
Healthcare
ELVN
50.05 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
19.88
52 week high
29.55
high
20.11
52 week low
0.00
low
19.08
growth
-17.25 %
previous Close
19.92
P/E ratio
market cap
1.04 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top